PGRMC2

PGRMC2 is a membrane-associated haem- and steroid-binding protein that functions as an intracellular haem chaperone delivering labile haem from mitochondria to the nucleus, thereby controlling the stability of haem-responsive transcriptional repressors (Rev-Erbα, BACH1) and coupling mitochondrial metabolism to gene expression (PMID:31748741). It forms a cytoplasmic complex with PGRMC1 and PAQR7 that mediates progesterone's antimitotic signaling independently of the classical nuclear progesterone receptor, and both PGRMC1 and PGRMC2 localize to the mitotic spindle where their depletion promotes aberrant cell-cycle entry and metaphase arrest (PMID:25253729, PMID:26203174). In reproductive tissues PGRMC2 regulates steroidogenic enzyme and nuclear progestin receptor expression to support oocyte maturation and ovulation, and at the maternal–fetal interface it maintains immune homeostasis by controlling HLA-G expression and inflammatory mediator release (PMID:31301284, PMID:39179795). In cardiomyocytes PGRMC2 mediates rapid steroid-coupled calcium signaling essential for normal pressure–volume relationships, and in astrocytes it modulates NF-κB–dependent polarization toward a neuroprotective phenotype (PMID:40069180, PMID:41699609).

1. 1998 Medium

   The initial cloning of PGRMC2 (then called Dg6) established it as a novel transmembrane protein with a putative steroid-binding domain preferentially expressed in placenta, framing all subsequent work on its steroid-related functions.

   Evidence cDNA cloning with tissue expression profiling and chromosomal mapping

   PMID:9705155

   Open questions at the time

   • No direct evidence of steroid binding was provided
   • Expression profile limited to mRNA; protein-level confirmation absent
   • No functional assay performed
2. 2014 Medium

   Demonstration that PGRMC1 and PGRMC2 physically interact, co-localize at the mitotic spindle, and jointly restrain cell-cycle entry answered how these paralogous membrane receptors cooperate and revealed an unexpected role in mitosis.

   Evidence Pull-down assays, in situ PLA, colocalization microscopy, and siRNA-mediated depletion with FUCCI cell-cycle analysis in human cells

   PMID:25253729

   Open questions at the time

   • Structural basis of the PGRMC1–PGRMC2 heterocomplex is unresolved
   • The mechanism by which the complex restrains G1 entry via G3BP2 is not defined
   • Spindle localization demonstrated only by overexpressed GFP fusions
3. 2015 Medium

   Identifying a PGRMC1–PGRMC2–PAQR7 cytoplasmic complex as the mediator of progesterone's antimitotic action — independent of classical PGR — resolved which receptors transduce non-genomic progesterone signals in granulosa/luteal cells.

   Evidence PLA interaction mapping combined with individual siRNA knockdown and FUCCI cell-cycle analysis in primary human granulosa/luteal cells

   PMID:26203174

   Open questions at the time

   • Downstream signaling cascade from the ternary complex is undefined
   • Stoichiometry and direct versus bridged interactions among the three proteins not established
   • Relevance beyond granulosa/luteal cells not tested
4. 2017 Medium

   Chemical proteomics identification of PGRMC2 as a ligandable target whose engagement promotes adipogenesis provided the first evidence that its activity could be pharmacologically modulated and linked it to metabolic differentiation programs.

   Evidence Fragment-based ligand discovery with isoTOP-ABPP quantitative chemical proteomics and adipocyte differentiation phenotypic screening

   PMID:28111073

   Open questions at the time

   • Binding site on PGRMC2 was not structurally resolved
   • Selectivity over PGRMC1 not fully characterized
   • Downstream mechanism connecting PGRMC2 engagement to adipogenic transcription undefined
5. 2019 High

   Adipose-specific Pgrmc2 knockout demonstrated that PGRMC2 serves as the principal intracellular haem chaperone shuttling labile haem from mitochondria to the nucleus, fundamentally redefining the protein's molecular function beyond steroid binding.

   Evidence Conditional KO in mouse brown adipose tissue with nuclear haem quantification, Rev-Erbα/BACH1 stability assays, mitochondrial phenotyping, metabolic profiling, and pharmacological rescue with a small-molecule activator

   PMID:31748741

   Open questions at the time

   • Whether haem chaperoning is the unifying mechanism behind PGRMC2's reproductive and cardiac roles is untested
   • Crystal structure of PGRMC2 bound to haem has not been reported
   • Identity of any co-chaperone or docking partner at the mitochondrial outer membrane is unknown
6. 2019 Medium

   Zebrafish pgrmc2 knockout and pgrmc1/pgrmc2 double-knockout studies demonstrated that PGRMC2 regulates female fertility by controlling steroidogenic enzyme expression, ovarian progestin levels, and nuclear progestin receptor (Pgr) protein abundance, revealing non-redundant roles of the two paralogues in ovulation.

   Evidence Germline KO and double-KO zebrafish with spawning, oocyte maturation, DHP measurement, RT-PCR, and western blotting for Pgr

   PMID:31301284 PMID:31536721

   Open questions at the time

   • Whether steroidogenic regulation is haem-dependent or reflects a separate PGRMC2 activity is unresolved
   • Mammalian ovarian conditional KO has not been reported
   • Mechanism by which PGRMC2 controls Pgr protein stability or transcription is unknown
7. 2024 Medium

   Functional studies at the maternal–fetal interface showed PGRMC2 maintains immune homeostasis by regulating HLA-G, inflammatory mediators, and mesenchymal–epithelial transition in chorion trophoblasts, and supports decidualization-dependent trophoblast expansion in endometrial stromal cells.

   Evidence PGRMC2 KO in trophoblasts on a microfluidic CDi-on-chip model with immune migration assays; siRNA KD in primary decidualized hEnSCs with RNA-seq, SWATH-MS proteomics, and trophoblast outgrowth assay

   PMID:38452349 PMID:39179795

   Open questions at the time

   • Specific signaling pathway linking PGRMC2 to HLA-G transcription not identified
   • In vivo uterine-specific KO during implantation not performed
   • Whether haem chaperoning underlies these immune-regulatory functions is untested
8. 2025 High

   Cardiomyocyte-specific Pgrmc2 deletion revealed that PGRMC2 mediates rapid steroid-coupled calcium transients required for normal cardiac pressure–volume relationships, extending its physiological relevance beyond metabolism and reproduction to cardiovascular function.

   Evidence Cardiomyocyte-specific conditional KO with pressure–volume loop hemodynamics, calcium signaling measurements, and hypoxic stress challenge in mice

   PMID:40069180

   Open questions at the time

   • Steroid identity (progesterone vs. other) triggering the calcium signal is not established
   • Whether calcium signaling requires haem-bound PGRMC2 is unknown
   • Downstream calcium effectors in cardiomyocytes not identified
9. 2025 Medium

   Uterine Pgrmc2 deletion in a Pten-loss cancer model reduced endometrial hyperplasia, decreased glandular proliferation, and extended survival, establishing PGRMC2 as a pro-proliferative factor in oncogenic contexts.

   Evidence Conditional uterine Pgrmc2 KO crossed into Pten heterozygous/null background with histopathology, proliferation assays, and survival analysis

   PMID:40227710

   Open questions at the time

   • Molecular mechanism linking PGRMC2 to Pten-dependent proliferation not defined
   • Relevance to human endometrial cancer prognosis untested
   • Whether this pro-proliferative effect is haem- or progesterone-dependent is unknown
10. 2026 Medium

    Astrocytic PGRMC2 overexpression shifted astrocyte polarization from neurotoxic A1 to neuroprotective A2 via NF-κB modulation and rescued cognitive deficits in AD mice, indicating a neuroinflammatory regulatory role.

    Evidence AAV-mediated astrocyte-specific PGRMC2 overexpression in APPswe/PSEN1dE9 mice with behavioral testing, MRI, and NF-κB/astrocyte-marker profiling

    PMID:41699609

    Open questions at the time

    • Gain-of-function design; loss-of-function in astrocytes not performed
    • Direct NF-κB binding or signaling intermediary not identified
    • Single AD model; generalizability to other neuroinflammatory conditions untested

• The central unresolved question is whether haem chaperoning is the unifying molecular mechanism underlying PGRMC2's diverse tissue-specific functions — steroidogenesis, calcium signaling, immune regulation, cell-cycle control — or whether PGRMC2 possesses mechanistically separable activities.
• No structural model of full-length PGRMC2 with haem or steroid ligand exists
• Haem-binding-deficient mutant has not been tested across tissue contexts
• Relationship between haem chaperoning and progesterone-dependent signaling is undefined